Name of License: Intent to Grant an Semi Exclusive License for U.S. Government Owned Inventions
Summary: In accordance with applicable laws and regulations, announcement is made of the intent to grant an exclusive, royalty-bearing, revocable, license within a field of use.
Tech Name:
Automated Three- and Four-Dimensional Ultrasound Quantification and Surveillance of Free Fluid in Body Cavities and Intravascular Volume
Address: Commander, Defense Health Agency, Research and Development, ATTN: Director, Office of Research and Technology Applications, 1520 Freedman Drive, Suite 227, Fort Detrick, MD 21702-5012.
For Further Information Contact: Dr. Rajendra Poudel, Office of Research & Technology Applications, (301) 619-4145. For patent issues, Ms. Leigh Callander, Supervisory Patent Attorney, (301) 619-7808.
Supplementary Information: : In accordance with 35 U.S.C. 209 (e) and 37 CFR 404.7 (a)(1)(i), announcement is made of the intent to grant an exclusive within a field of use, royalty-bearing, revocable license agreement to U.S. Patent Number 11,123,042 B2 issued on September 21, 2021, entitled “Automated Three- and Four-Dimensional Ultrasound Quantification and Surveillance of Free Fluid in Body Cavities and Intravascular Volume” to Airion Health LLC, having its corporate headquarters at 5352 Sterling Center, Drive, West Lake Village, CA 91361. Anyone wishing to object to grant of this option can file written objections along with supporting evidence, if any, within 15 days from the date of this publication. Written objections are to be filed with the Director, Office of Research and Technology Applications (see